These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1959939)
1. Anti-murine IL-6 receptor antibody inhibits IL-6 effects in vivo. Suzuki H; Yasukawa K; Saito T; Anzai M; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T Immunol Lett; 1991 Sep; 30(1):17-21. PubMed ID: 1959939 [TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Pallua N; Low JF; von Heimburg D Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624 [TBL] [Abstract][Full Text] [Related]
3. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Suzuki H; Yasukawa K; Saito T; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T Eur J Immunol; 1992 Aug; 22(8):1989-93. PubMed ID: 1639101 [TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Tamura T; Udagawa N; Takahashi N; Miyaura C; Tanaka S; Yamada Y; Koishihara Y; Ohsugi Y; Kumaki K; Taga T Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11924-8. PubMed ID: 8265649 [TBL] [Abstract][Full Text] [Related]
5. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315 [TBL] [Abstract][Full Text] [Related]
6. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Kitani A; Hara M; Hirose T; Harigai M; Suzuki K; Kawakami M; Kawaguchi Y; Hidaka T; Kawagoe M; Nakamura H Clin Exp Immunol; 1992 Apr; 88(1):75-83. PubMed ID: 1563109 [TBL] [Abstract][Full Text] [Related]
7. Effect of interleukin-6 on the growth of human lung cancer cell line. Fu J; Zheng J; Fang W; Wu B Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431 [TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Suzuki H; Yasukawa K; Saito T; Narazaki M; Hasegawa A; Taga T; Kishimoto T Eur J Immunol; 1993 May; 23(5):1078-82. PubMed ID: 8477802 [TBL] [Abstract][Full Text] [Related]
9. A monoclonal anti-human IL-6 receptor antibody inhibits the proliferation of human myeloma cells. Huang YW; Vitetta ES Hybridoma; 1993 Oct; 12(5):621-30. PubMed ID: 8300137 [TBL] [Abstract][Full Text] [Related]
10. Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro. Goto H; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Koishihara Y Jpn J Cancer Res; 1994 Sep; 85(9):958-65. PubMed ID: 7961126 [TBL] [Abstract][Full Text] [Related]
12. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800 [TBL] [Abstract][Full Text] [Related]
13. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Novick D; Shulman LM; Chen L; Revel M Cytokine; 1992 Jan; 4(1):6-11. PubMed ID: 1617157 [TBL] [Abstract][Full Text] [Related]
18. Micro-concentration Lipopolysaccharide as a Novel Stimulator of Megakaryocytopoiesis that Synergizes with IL-6 for Platelet Production. Wu D; Xie J; Wang X; Zou B; Yu Y; Jing T; Zhang S; Zhang Q Sci Rep; 2015 Sep; 5():13748. PubMed ID: 26330186 [TBL] [Abstract][Full Text] [Related]
19. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523 [TBL] [Abstract][Full Text] [Related]
20. IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease. Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M J Invest Dermatol; 2012 Dec; 132(12):2752-61. PubMed ID: 22810302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]